Amarin Soars as Fish Oil Pill Cuts Risk of Strokes in Long-Awaited Study

Xconomy New York — Amarin Soars as Fish Oil Pill Cuts Risk of Strokes in Long-Awaited Study Can fish oil help prevent, or reduce the risk of heart disease? Several studies have failed to show that it can. But Amarin this morning is releasing data from a massive study showing that its prescription-grade fish oil […]

SeaDragon appoints new Chief Executive

NZX / MEDIA RELEASE 18 July 2016. Link here. SeaDragon appoints new Chief Executive Dr Nevin Amos to take the reins of the company in October 2016. SeaDragon Board thanks outgoing Interim Chief Executive Richard Alderton for leadership through the company’s transition to Omega-3 fish oil markets SeaDragon, New Zealand’s largest refiner and blender of […]

SeaDragon – Market Update

NZX / MEDIA RELEASE 26 April 2016. Link here. Omega-3 update; Omega-2 sales slow; Revised financial guidance SeaDragon Limited (NZX:SEA) is pleased to update the market on the following recent events. Omega-3 Refinery As previously noted to the market, the commissioning of SeaDragon’s new Omega-3 refinery has been successfully completed, with the plant meeting performance […]

SeaDragon raises $10.009 million

SEA: NZX and Media Release 30 September 2015. NZX link here. SeaDragon raises $10.009 million via rights offer and shortfall bookbuild, and additional placement Successful capital raising at $0.008 per share facilitates the completion of the company’s new Omega-3 fish oil refinery. New Zealand’s leading refiner and blender of high-quality fish oils SeaDragon Limited (NZX:SEA) today […]

Sea Dragon – Market Update

28 July 2015. Link here. SeaDragon Limited (NZX:SEA) today releases an update to the market detailing the company’s progress towards completing the Omega-3 production plant. The update also includes an overview of; • Key products • Customers • The rationale for investment in SeaDragon • The use of proceeds • Financial forecasts • Sustainability statement For […]

SeaDragon Annual Report 2014-2015

30 June 2015. Link here. SeaDragon annual report, including audited financial statements, for the year to 31 March 2015.

SeaDragon streamlines Board

SEA: NZX and Media Release 29 June 2015. Link here. Board reduced to five with focus on supply chain and production; outgoing CEO named Honorary President SeaDragon Limited (NZX:SEA) today announces a number of Director changes as it adds production and supply chain management experience to the Board in preparation for the company’s move into the […]

SeaDragon raises up to $2.5M with convertible loan

9:53am, 24 Jun 2015 SEA: NZX and Media Release 24 June 2015 Link here. SeaDragon raises up to $2.5M with convertible loan; signals capital raising Richard Alderton appointed Interim Chief Executive Officer SeaDragon Limited (NZX:SEA) today announces that one of its cornerstone shareholders, BioScience Managers, has agreed to advance the company up to NZ$2.5 million via […]

SeaDragon Full Year Result to 31 March 2015

FINANCIAL RESULTS FOR THE 12 MONTHS TO 31 MARCH 2015. Link here. SeaDragon annual sales double; Omega 3 refinery on track for start-up in Q4 2015 Highlights: • New Omega 3 fish oil refinery on track for commissioning later this year, realising a 10 year strategic plan • Additional Squalene raw material supply contracts position SeaDragon for […]

SeaDragon appoints Chairman

SEA: NZX MARKET UPDATE 8 May 2015 Link here. SeaDragon appoints Chairman with strong international market expertise SeaDragon, New Zealand’s largest refiner and blender of high quality, fish oils and fractions, including Omega 3 oils, is pleased to announce it has appointed Colin Groves as Chairman. Mr Groves has spent the past 23 years primarily as Director […]